Abbott’s new device aims to prevent diabetic ketoacidosis with dual glucose and ketone monitoring

Abbott’s latest FDA-approved wearable introduces continuous real-time monitoring of both glucose and ketones, potentially transforming diabetes management and early detection of ketoacidosis. Victoria Song’s memory of a teenage hospital dash is not just an anecdote about a foolish diet. It…













